Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06817408 · ClinicalTrials.gov registry record
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
A clinical trial of Sepsis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06817408 is a study of Sepsis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000 participants, below the 6,554-participant average among 90 other Sepsis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06817408, a study of Sepsis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
Conditions Studied
Interventions
- OTHER Observation
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-03-25 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06817408
The ClinicalTrials.gov registry entry for NCT06817408 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,554-participant average among 90 other Sepsis trials with a reported enrollment target (85% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT06817408 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06817408 about?
NCT06817408 is a clinical study titled "Dynamics of Organ Damage and Immune Exhaustion During Sepsis". This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
What is the current status of trial NCT06817408?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-03-25. Estimated completion is 2026-12.
What conditions does trial NCT06817408 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT06817408?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT06817408?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06817408 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.